Arcoxia: Targeted Relief for Chronic Inflammatory Pain Conditions
| Product dosage: 120mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.20 | $36.12 (0%) | 🛒 Add to cart |
| 60 | $0.90 | $72.24 $54.18 (25%) | 🛒 Add to cart |
| 90 | $0.79 | $108.36 $71.38 (34%) | 🛒 Add to cart |
| 120 | $0.75 | $144.48 $90.30 (38%) | 🛒 Add to cart |
| 180 | $0.70 | $216.72 $125.56 (42%) | 🛒 Add to cart |
| 270 | $0.67 | $325.08 $179.74 (45%) | 🛒 Add to cart |
| 360 | $0.65
Best per pill | $433.44 $233.06 (46%) | 🛒 Add to cart |
| Product dosage: 60mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.75 | $44.72 (0%) | 🛒 Add to cart |
| 90 | $0.67 | $67.08 $60.20 (10%) | 🛒 Add to cart |
| 120 | $0.62 | $89.44 $74.82 (16%) | 🛒 Add to cart |
| 180 | $0.59 | $134.16 $105.78 (21%) | 🛒 Add to cart |
| 270 | $0.56 | $201.24 $152.22 (24%) | 🛒 Add to cart |
| 360 | $0.55
Best per pill | $268.32 $199.52 (26%) | 🛒 Add to cart |
| Product dosage: 90mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.80 | $48.16 (0%) | 🛒 Add to cart |
| 90 | $0.72 | $72.24 $64.50 (11%) | 🛒 Add to cart |
| 120 | $0.67 | $96.32 $80.84 (16%) | 🛒 Add to cart |
| 180 | $0.63 | $144.48 $112.66 (22%) | 🛒 Add to cart |
| 270 | $0.60 | $216.72 $161.68 (25%) | 🛒 Add to cart |
| 360 | $0.58
Best per pill | $288.96 $209.84 (27%) | 🛒 Add to cart |
Synonyms | |||
Arcoxia (etoricoxib) is a prescription-only selective COX-2 inhibitor belonging to the class of nonsteroidal anti-inflammatory drugs (NSAIDs). It is specifically engineered to provide potent anti-inflammatory and analgesic effects while minimizing the gastrointestinal complications traditionally associated with non-selective NSAIDs. Clinically indicated for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gouty arthritis, Arcoxia works by selectively inhibiting the cyclooxygenase-2 (COX-2) enzyme, which is responsible for inflammation and pain. This mechanism allows for effective symptom management with a targeted approach, making it a valuable option in chronic pain management protocols where long-term therapy is required.
Features
- Active ingredient: Etoricoxib
- Drug class: Selective COX-2 inhibitor NSAID
- Available in tablet formulations: 60 mg, 90 mg, and 120 mg
- Prescription-only medication requiring medical supervision
- Once-daily oral dosing for consistent therapeutic coverage
- Not indicated for use in pediatric populations
- Manufactured under strict pharmaceutical quality standards
Benefits
- Provides powerful and sustained relief from inflammatory pain and stiffness associated with chronic arthritic conditions.
- Reduces the risk of gastrointestinal ulcers and bleeding compared to traditional non-selective NSAIDs due to its selective mechanism.
- Offers convenient once-daily dosing, supporting medication adherence and consistent symptom control.
- Improves physical function and quality of life in patients with osteoarthritis and rheumatoid arthritis.
- Effectively manages acute pain flares in conditions such as gouty arthritis.
- Allows for individualized dosing based on specific condition severity and patient response.
Common use
Arcoxia is commonly prescribed for the management of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gouty arthritis. It is also used in the treatment of chronic musculoskeletal pain and dysmenorrhea in certain jurisdictions, subject to local regulatory approvals. Its use is generally reserved for patients who have not achieved satisfactory pain relief with first-line analgesics or who are at increased risk of gastrointestinal complications with traditional NSAIDs.
Dosage and direction
The recommended dose of Arcoxia should be individualized based on the patient’s condition and response. For osteoarthritis, the usual dose is 60 mg once daily. For rheumatoid arthritis, 90 mg once daily is standard. In acute gouty arthritis, 120 mg once daily is recommended for a limited duration of up to 8 days. For ankylosing spondylitis, the dose is 90 mg once daily. Tablets should be taken orally, with or without food. The lowest effective dose should be used for the shortest duration necessary to control symptoms. Dose adjustment may be required in elderly patients and those with hepatic impairment.
Precautions
Arcoxia should be used with caution in patients with a history of cardiovascular disease, hypertension, heart failure, or edema. Renal function should be monitored in patients with pre-existing renal impairment, dehydration, or those taking concomitant medications that affect kidney function. Patients with a history of asthma, aspirin-sensitive asthma, or allergic reactions to NSAIDs should avoid Arcoxia. Gastrointestinal risks, though reduced compared to non-selective NSAIDs, still exist—particularly in elderly patients or those with a history of ulcers. Periodic blood pressure monitoring is advised during treatment.
Contraindications
Arcoxia is contraindicated in patients with known hypersensitivity to etoricoxib or any component of the formulation. It must not be used in patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Use is contraindicated in patients with active peptic ulceration or gastrointestinal bleeding, severe hepatic dysfunction (Child-Pugh score ≥9), estimated creatinine clearance <30 mL/min, inflammatory bowel disease, congestive heart failure (NYHA Class II–IV), established ischemic heart disease, peripheral arterial disease, and/or cerebrovascular disease. It is also contraindicated in the third trimester of pregnancy and during breastfeeding.
Possible side effect
Common side effects may include dizziness, headache, edema, hypertension, dyspepsia, abdominal pain, nausea, and fatigue. Less frequently, rash, pruritus, palpitations, fluid retention, and elevated liver enzymes may occur. Serious but rare adverse effects include gastrointestinal ulceration or bleeding, severe cutaneous reactions (e.g., Stevens-Johnson syndrome), hepatotoxicity, acute renal failure, and cardiovascular events such as myocardial infarction or stroke. Patients should seek immediate medical attention if symptoms such as chest pain, shortness of breath, weakness on one side of the body, black stools, or severe skin reactions develop.
Drug interaction
Arcoxia may interact with several medications. Concomitant use with other NSAIDs or aspirin may increase the risk of gastrointestinal adverse events. It may reduce the effectiveness of ACE inhibitors, angiotensin II receptor antagonists, and diuretics, and can increase lithium and methotrexate levels. Co-administration with warfarin or other anticoagulants may enhance anticoagulant effects and increase bleeding risk. Use with cyclosporine or tacrolimus may increase nephrotoxicity. Rifampicin and other CYP3A4 inducers may decrease etoricoxib plasma concentrations. Healthcare providers should review all concomitant medications before initiation.
Missed dose
If a dose is missed, it should be taken as soon as remembered, unless it is almost time for the next scheduled dose. In that case, the missed dose should be skipped, and the regular dosing schedule resumed. Doubling the dose to make up for a missed one is not recommended.
Overdose
Symptoms of overdose may include lethargy, drowsiness, nausea, vomiting, epigastric pain, gastrointestinal bleeding, hypertension, acute renal failure, or respiratory depression. There is no specific antidote for etoricoxib overdose. Management is supportive and symptomatic, including gastric lavage or activated charcoal (if presented early), and monitoring of vital signs, renal function, and electrolyte balance. Hemodialysis is not likely to be effective due to high protein binding.
Storage
Store Arcoxia tablets at room temperature (15–30°C), in a dry place, protected from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any new medication or changing your treatment plan. Do not disregard or delay seeking medical advice based on content provided here.
Reviews
Clinical studies and patient reports indicate that Arcoxia is effective in reducing pain and improving function in chronic inflammatory conditions. Many users report significant improvement in quality of life, with particular appreciation for its once-daily dosing and reduced gastrointestinal side effects compared to traditional NSAIDs. However, individual responses may vary, and some patients may not experience adequate relief or may encounter side effects. Long-term tolerability and cardiovascular safety continue to be monitored in post-marketing surveillance.